Results 201 to 210 of about 82,694 (258)

Reducing Contrast-Induced Nephropathy Risk in a Murine Model: Role of Avanafil and Vardenafil in Modulating Oxidant/Antioxidant Balance. [PDF]

Cureus
Mavridis C, Zisis IE, Docea AO, Buga AM, Tsatsakis A, Mamoulakis C.   +5 more
europepmc   +1 more source

Effects of Psyllium Husk on Metabolic Regulators, Insulin Resistance, and SIRT6 in Liver and Muscle of Type 2 Diabetic Rats

Veterinary Medicine and Science, Volume 12, Issue 3, May 2026.
The effects of psyllium husk supplementation on metabolic regulators, insulin resistance markers, and SIRT6 expression in the liver and skeletal muscle tissues of type 2 diabetic rats were investigated. PHP demonstration has significant beneficial effects by partially improving metabolic dysfunctions and increasing antioxidant capacity in T2DM ...
Furkan Ümit, Gülay Çiftci, Burcu Onuk, Recai Aci, Özüm Çaka, Alper Çiftci   +5 more
wiley   +1 more source

Nicorandil in preventing contrast-induced nephropathy in patients undergoing cardiac catheterization procedures: a systematic review and meta-analysis. [PDF]

Ann Med Surg (Lond)
Waseem R, Kumar A, Kumari S, Kumar S, Bai D, Kumar G, Jabbar M, Ashraf T, Nancy F, Mariam B, Dev S, Turesh M, Yousuf MH, Ejaz U, Jawad S.   +14 more
europepmc   +1 more source

Proximal ureteral fibroepithelial polyp with secondary renal atrophy in a dog (Canis lupus familiaris)

Veterinary Record Case Reports, Volume 14, Issue 2, May 2026.
Abstract A 12‐year‐old, male intact, Papillon dog was presented following trauma from a motor vehicle accident. On arrival, the dog was laterally recumbent with neurological dysfunction (modified Glasgow coma scale 12) and multiple injuries, including right hip luxation and suspected haemorrhage.
Charles T. Talbot, Xiaobo Wang, Ji‐Hang Yin   +2 more
wiley   +1 more source

Contrast-Induced Nephropathy (CIN) After Invasive Treatment of Acute Coronary Syndromes-Predictors, Short and Long-Term Outcome. [PDF]

J Clin Med
Sielski J, Kaziród-Wolski K, Piotrowska AM, Jurczak B, Klasa A, Kozieł K, Ludew M, Maj F, Merchel L, Pytlak K, Zabojszcz M, Siudak Z.   +11 more
europepmc   +1 more source

Novel drugs approved by the EMA, the FDA and the MHRA in 2025: A year in review

British Journal of Pharmacology, Volume 183, Issue 9, Page 1779-1813, May 2026.
Abstract In the 2025 novel drug mini‐review, one can take a full measure of the ingenuity that underlies current drug design and development, despite the year's smaller harvest (46 novel drugs) compared to 2024 (53) and 2023 (70). 54% of the novel drugs are first‐in‐class (FIC).
Andreas Papapetropoulos, Stavros Topouzis, Steve P. H. Alexander, Miriam M. Cortese‐Krott, Zsuzsanna Helyes, Kirill Martemyanov, Claudio Mauro, Nithyanandan Nagercoil, Reynold A. Panettieri Jr, Hemal H. Patel, Rainer Schulz, Barbara Stefanska, Gary J. Stephens, Nathalie Vergnolle, Xin Wang, Stephen Ward, Péter Ferdinandy   +16 more
wiley   +1 more source

The role of carbon dioxide angiography in reducing contrast-induced nephropathy in diabetic foot patients undergoing endovascular treatment. [PDF]

Turk J Med Sci
Uyanik SA, Birgi E, Öztürk S, Asfuroğlu U, Tangobay E, Güven HE.   +5 more
europepmc   +1 more source

Risk Factors for the Recurrence of Massive Hemoptysis Treated With Bronchial Artery Embolization: A Retrospective Study

The Clinical Respiratory Journal, Volume 20, Issue 5, May 2026.
This study preliminarily concludes that the extent of destroyed lung, whether preoperative CTA, technical factors, and the progression of underlying diseases are independent risk factors associated with hemoptysis recurrence after bronchial artery embolization (BAE). Through comprehensive preoperative assessments, individualized embolization strategies,
Tianhua Yue, Ling Li, Zhengyu Yue
wiley   +1 more source

Experimental study of intravoxel incoherent motion diffusion imaging combined with ultrasound renal resistance index in contrast-induced nephropathy. [PDF]

BMC Nephrol
Chen J, Song X, Wang Z, Wang Z.
europepmc   +1 more source